Why the study?
Does measuring H-FABP along with troponin improve risk stratification in patients with suspected acute coronary syndrome?
Population
Patients with suspected acute coronary syndrome (ACS)
Design
Review
Authors
Loading...
May support adjunctive H-FABP for early ACS risk stratification; leaves open need for prospective trials before practice change.
Does measuring H-FABP along with troponin improve risk stratification in patients with suspected acute coronary syndrome?
H-FABP provides added value to cardiac troponin for early risk stratification in patients with suspected ACS.
Glatz et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: